Access to Medicines

Rational Use of Medicines

  • In primary care in developing and transitional countries, less than 40 percent of patients in the public sector and 30 percent of patients in the private sector are treated in accordance with standard treatment guidelines. (The World Medicines Situation 2011: Rational Use of Medicines, World Health Organization, 2011)

Clinical Trial Data Transparency

Antimicrobial Resistance

Research & Development

  • Only four of 97 new medicines or indications rated by Prescrire in 2010 provided any therapeutic advantage. (Revue Prescrire, 2011)

Health Action International’s staff and network have unparalleled expertise in all areas of pharmaceutical policy, including intellectual property, pharmaceutical R&D, free trade, pharmaceutical marketing, clinical trial data transparency and pharmaceutical pricing.

To arrange an interview, or book them to speak at an event, please contact our media team.

START TYPING AND PRESS ENTER TO SEARCH